TW0006547003
TW0006547003
MEDIGEN VACCINE BIOLOGICS CORPO
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 613.171.000 | 605.637.000 | 1.2% |
| Cost of Revenue | 248.497.000 | 209.215.000 | 18.8% |
| Gross Profit | 364.674.000 | 396.422.000 | 8.0% |
| 630.365.000 | 542.088.000 | 16.3% | |
| Operating Income | -265.691.000 | -145.666.000 | 82.4% |
| Pretax Income | -281.714.000 | -80.465.000 | 250.1% |
| Net Income Common Stockholders | -281.714.000 | -80.465.000 | 250.1% |
| -- | -- | -- | |
| -- | -- | -- |